Waterloo Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215K Sell
2,484
-1,295
-34% -$124K 0.02% 458
2025
Q4
$363K Buy
3,779
+143
+4% +$13.9K 0.03% 342
2025
Q3
$346K Buy
3,636
+1,123
+45% +$103K 0.03% 341
2025
Q2
$219K Buy
+2,513
New +$213K 0.02% 428
2024
Q3
Sell
-6,010
Closed -$473K 376
2024
Q2
$473K Sell
6,010
-154
-2% -$12.6K 0.06% 229
2024
Q1
$537K Sell
6,164
-463
-7% -$39.5K 0.07% 216
2023
Q4
$546K Buy
+6,627
New +$505K 0.09% 197

Other funds holding MDT

Waterloo Capital's MDT Position: Q1 2026 in Review

Waterloo Capital reduced its Medtronic (MDT) stake by 34% in Q1 2026, selling an estimated $124K and leaving 2,484 shares worth $215K. The position accounts for 0.02% of the portfolio, ranked #458.

Waterloo Capital first reported a position in MDT in Q4 2023 and has held it in 7 quarters since. The position peaked at $546K in Q4 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Waterloo Capital held 2,484 shares of Medtronic worth $215K as of Q1 2026.
  • Waterloo Capital sold 1,295 Medtronic shares in Q1 2026, an estimated $124K.
  • Medtronic made up 0.02% of Waterloo Capital's portfolio in Q1 2026, its #458 holding.
  • Waterloo Capital first reported a position in Medtronic in Q4 2023 and has held it in 7 quarters since.
  • Waterloo Capital's Medtronic position peaked at $546K in Q4 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.